30
Participants
Start Date
October 22, 2018
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
Lactobacillus PS11603 & Bifidobacterium PS10402
Approximately 8 weeks intervention study: Participants with 0-5 days of age will start a period of 8 weeks of intervention. During this time the participants will intake one daily dose of the product that contains 1\*10E9 CFU of L.salivarius PS11603 and 1\*10E8 CFU of B.longum PS10402.
Placebo
8 weeks intervention study: A 8 weeks intervention period. During the 8 weeks of intervention the participants will intake one daily dose of placebo supplement.
Hospital Universitario La Paz, Madrid
ProbiSearch SL
INDUSTRY